[fcb5af]: / literature / by_gene / IL6.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 33764527 10.1002/cncr.33454 2022 Screening and identification of a novel FHL2 mutation by whole exome sequencing in twins with familial Waldenström macroglobulinemia. IL6
2 34009095 10.1080/09273948.2021.1878233 2022 Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma. IL6
3 34039950 10.1038/s41408-021-00493-5 2022 Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. IL6
4 34078642 10.1158/1055-9965.EPI-20-1704 2022 Cytokine Levels at Birth in Children Who Developed Acute Lymphoblastic Leukemia. IL6
5 34131000 10.1158/1078-0432.CCR-20-4167 2022 Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study. IL6
6 34509934 10.1016/j.intimp.2021.108138 2022 LncRNA THUMPD3-AS1 enhances the proliferation and inflammatory response of chondrocytes in osteoarthritis. IL6
7 34542753 10.1007/s10517-021-05268-3 2022 Changes in Bone Marrow Stromal Progenitor Cells in Patients with Hematoblastosis at the Onset of the Disease. IL6
8 34691064 10.3389/fimmu.2021.750114 2022 Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults. IL6
9 34788985 10.3324/haematol.2021.279631 2022 Mutational landscape of high-grade B-cell lymphoma with <i>MYC-</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements characterized by whole-exome sequencing. IL6
10 34935301 10.1002/vms3.694 2022 Neutrophilic leucocytosis induced by granulocyte colony-stimulating factor and interleukin-6 in canine primary lung adenocarcinoma. IL6
11 35008292 10.3390/cancers14010128 2022 Increased Production of B-Cell Activating Cytokines and Altered Peripheral B-Cell Subset Distribution during HIV-Related Classical Hodgkin Lymphoma. IL6
12 35014680 10.3892/mmr.2022.12592 2022 Role of TGM2 in T‑cell lymphoblastic lymphoma via regulation of IL‑6/JAK/STAT3 signalling. IL6
13 35021606 10.3324/haematol.2021.280003 2022 Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS. IL6
14 35147475 10.1080/10428194.2022.2038373 2022 Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma. IL6
15 35158867 10.3390/cancers14030598 2022 Diagnosing Vitreoretinal Lymphomas-An Analysis of the Sensitivity of Existing Tools. IL6
16 35186744 10.3389/fonc.2022.808511 2022 Clinical Features, Diagnosis, Management and Prognosis of Primary Intraocular Lymphoma. IL6
17 35187467 10.1016/j.clinpr.2022.100137 2022 Higher mortality of hospitalized haematologic patients with COVID-19 compared to non-haematologic is driven by thrombotic complications and development of ARDS: An age-matched cohorts study. IL6
18 35345499 10.2147/IMCRJ.S345149 2022 A Case of Intraocular Lymphoma Diagnosed by Subretinal Fluid Biopsy. IL6
19 35349392 10.1080/15384101.2022.2054096 2022 MCL-1 is a clinically targetable vulnerability in breast cancer. IL6
20 35399163 10.1155/2022/1840589 2022 Siltuximab-Related Favorable Clinical Outcome for a Patient Suffering from Idiopathic Multicentric Castleman Disease. IL6
21 35432366 10.3389/fimmu.2022.856039 2022 IL-6 and IL-10 Are Associated With Gram-Negative and Gram-Positive Bacteria Infection in Lymphoma. IL6
22 35546979 10.22092/ari.2021.356202.1803 2022 Renoprotective Potential of the Ultra-Pure Lipopolysaccharide from Rhodobacter Sphaeroides on Acutely Injured Kidneys in an Animal Model. IL6
23 35642002 10.1186/s12967-022-03451-2 2022 Role of chemokine-mediated angiogenesis in resistance towards crizotinib and its reversal by anlotinib in EML4-ALK positive NSCLC. IL6
24 35884913 10.3390/biomedicines10071608 2022 Downregulation of STAT3 in Epstein-Barr Virus-Positive Hodgkin Lymphoma. IL6
25 35997599 10.1089/vim.2021.0224 2022 Expression Pattern of Inflammatory and Anti-Inflammatory Cytokines and Key Differential Transcription Factors in Peripheral Blood Mononuclear Cells of Iranian Coronavirus Disease 2019 Patients with Different Disease Severity. IL6
26 36098043 10.1002/jcla.24689 2022 Logistic regression models of cytokines in differentiating vitreoretinal lymphoma from uveitis. IL6
27 30443842 10.1007/s12253-018-0536-z 2021 The Expression of Interferon Gamma (IFN-γ) and Interleukin 6 (IL6) in Patients with Acute Lymphoblastic Leukemia (ALL). IL6
28 32118299 10.1111/bjh.16523 2021 Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche. IL6
29 32270320 10.1007/s00403-020-02062-5 2021 The polymorphisms of IL-6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility. IL6
30 32614271 10.1089/jir.2020.0012 2021 Interleukin-6-Mediated Inflammation May Cause Methotrexate-Induced Leukoencephalopathy. IL6
31 32669372 10.1158/1078-0432.CCR-20-1434 2021 Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel. IL6
32 32767331 10.26355/eurrev_202008_22488 2021 Correlations of IL-6 and IL-10 gene polymorphisms with childhood acute lymphoblastic leukemia. IL6
33 32808859 10.1080/10799893.2020.1808678 2021 Regulation of cell activation by A20 through STAT signaling in acute lymphoblastic leukemia. IL6
34 32859946 10.1038/s41540-020-00145-7 2021 Mitigating the risk of cytokine release syndrome in a Phase I trial of CD20/CD3 bispecific antibody mosunetuzumab in NHL: impact of translational system modeling. IL6
35 32926412 10.1002/jmv.26516 2021 Evaluation of IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ cytokines in HIV/HHV-8 coinfection. IL6
36 32998963 10.1158/1078-0432.CCR-20-1739 2021 Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy. IL6
37 33154497 10.1038/s41598-020-76206-y 2021 Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis. IL6
38 33246336 10.1093/humrep/deaa291 2021 N-acetylcysteine protects ovarian follicles from ischemia-reperfusion injury in xenotransplanted human ovarian tissue. IL6
39 33247999 10.1111/cas.14752 2021 Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer. IL6
40 33397158 10.1080/14737140.2021.1853531 2021 High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL). IL6
41 33403488 10.1007/s12015-020-10107-5 2021 Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient. IL6
42 33578562 10.1097/MD.0000000000024598 2021 Clinical prognosis and bioinformatic analysis of primary thyroid lymphoma. IL6
43 33771682 10.1016/j.etap.2021.103639 2021 Interleukin-6 reverses Adriamycin resistance in nasal NK/T-cell lymphoma via downregulation of ABCC4 and inactivation of the JAK2/STAT3/NF-κB/P65 pathway. IL6
44 33907185 10.1038/s41421-021-00255-4 2021 CRISPR-edited CART with GM-CSF knockout and auto secretion of IL6 and IL1 blockers in patients with hematologic malignancy. IL6
45 33958640 10.1038/s41598-021-88963-5 2021 Interplay between IL6 and CRIM1 in thiopurine intolerance due to hematological toxicity in leukemic patients with wild-type NUDT15 and TPMT. IL6
46 34071407 10.3390/cancers13112665 2021 Liquid Biopsy and Other Non-Invasive Diagnostic Measures in PCNSL. IL6
47 34090412 10.1186/s12890-021-01553-z 2021 EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation. IL6
48 34535012 10.1182/bloodadvances.2021004562 2021 Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations. IL6
49 28018176 10.3389/fncel.2016.00283 2020 Activated Microglia Induce Bone Marrow Mesenchymal Stem Cells to Produce Glial Cell-Derived Neurotrophic Factor and Protect Neurons Against Oxygen-Glucose Deprivation Injury. IL6
50 28337303 2020 The involvement and possible mechanism of NR4A1 in chondrocyte apoptosis during osteoarthritis. IL6
51 29593668 10.3389/fmicb.2018.00380 2020 Simulation Study of cDNA Dataset to Investigate Possible Association of Differentially Expressed Genes of Human THP1-Monocytic Cells in Cancer Progression Affected by Bacterial Shiga Toxins. IL6
52 29911923 10.1080/10428194.2018.1461861 2020 MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia. IL6
53 30333224 10.1158/1078-0432.CCR-18-1047 2020 Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies. IL6
54 30368882 10.1002/jcb.27671 2020 MAPKs and NF-κB-mediated acrylamide-induced neuropathy in rat striatum and human neuroblastoma cells SY5Y. IL6
55 30668205 10.1080/10428194.2018.1554861 2020 Alterations in multipotent mesenchymal stromal cells from the bone marrow of acute myeloid leukemia patients at diagnosis and during treatment. IL6
56 30825517 10.1016/j.exphem.2019.02.005 2020 Difference in megakaryocyte expression of GATA-1, IL-6, and IL-8 associated with maintenance of platelet counts in patients with plasma cell neoplasm with dysmegakaryopoiesis. IL6
57 31355491 10.1111/imr.12768 2020 Cellular therapy: Immune-related complications. IL6
58 31417180 10.1038/s41388-019-0921-4 2020 T-cell acute lymphoblastic leukemia displays autocrine production of Interleukin-7. IL6
59 31432169 10.3892/mmr.2019.10565 2020 Inhibition of microRNA‑124‑3p protects against acute myocardial infarction by suppressing the apoptosis of cardiomyocytes. IL6
60 31515941 10.15252/emmm.201910576 2020 The IL-6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B-cell lymphoma. IL6
61 31561022 10.1016/j.vetimm.2019.109940 2020 Canine multicentric lymphoma exhibits systemic and intratumoral cytokine dysregulation. IL6
62 31568628 10.1111/jcmm.14653 2020 Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cells. IL6
63 31599429 10.26355/eurrev_201909_19020 2020 Influence of lncRNA-MALAT1 on neuronal apoptosis in rats with cerebral infarction through regulating the ERK/MAPK signaling pathway. IL6
64 31601188 10.1186/s12885-019-6057-7 2020 Interleukin-6 mediates resistance to PI3K-pathway-targeted therapy in lymphoma. IL6
65 31678006 10.1016/j.bmcl.2019.126743 2020 Discovery and optimization of a series of small-molecule allosteric inhibitors of MALT1 protease. IL6
66 31886296 10.1155/2019/2137538 2020 Impact of SNPs/Haplotypes of <i>IL10</i> and <i>IFNG</i> on the Development of Diffuse Large B-Cell Lymphoma. IL6
67 31894295 10.3892/ijmm.2019.4434 2020 MicroRNA‑15a‑5p induces pulmonary artery smooth muscle cell apoptosis in a pulmonary arterial hypertension model via the VEGF/p38/MMP‑2 signaling pathway. IL6
68 32034308 10.1038/s41388-020-1183-x 2020 Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma. IL6
69 32124188 10.1007/s10552-020-01266-4 2020 Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study. IL6
70 32312819 10.1073/pnas.1913707117 2020 Starvation and antimetabolic therapy promote cytokine release and recruitment of immune cells. IL6
71 32362606 10.4103/jcrt.JCRT_137_17 2020 Interleukin 6 and disease transformation in chronic myeloid leukemia: A Northeast Indian population study. IL6
72 32457601 10.3389/fphar.2020.00519 2020 An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid. IL6
73 32473488 10.1016/j.leukres.2020.106371 2020 High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era. IL6
74 32565964 10.3892/ol.2020.11552 2020 Comprehensive characterization of driver genes in diffuse large B cell lymphoma. IL6
75 32673688 10.1016/j.exphem.2020.07.003 2020 Analysis of IL-6 serum levels and CAR T cell-specific digital PCR in the context of cytokine release syndrome. IL6
76 28674400 10.1038/s41598-017-04890-4 2019 Endotoxin tolerance in mast cells, its consequences for IgE-mediated signalling, and the effects of BCL3 deficiency. IL6
77 29496539 10.1016/j.canlet.2018.02.036 2019 Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer. IL6
78 29504848 10.1080/08916934.2018.1446525 2019 Signalling pathways identified in salivary glands from primary Sjögren's syndrome patients reveal enhanced adipose tissue development. IL6
79 29866021 10.2174/1871520618666180604093802 2019 Curcumin Modulates Glycolytic Metabolism and Inflammatory Cytokines via Nrf 2 in Dalton's Lymphoma Ascites Cells In Vivo. IL6
80 29880584 10.1158/2159-8290.CD-17-1319 2019 Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia. IL6
81 30066022 10.1007/s00210-018-1550-0 2019 Perindopril regulates the inflammatory mediators, NF-κB/TNF-α/IL-6, and apoptosis in cisplatin-induced renal dysfunction. IL6
82 30097433 10.1158/1078-0432.CCR-18-0426 2019 A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia. IL6
83 30217873 10.1158/0008-5472.CAN-18-0831 2019 Neonatal Inflammatory Markers Are Associated with Childhood B-cell Precursor Acute Lymphoblastic Leukemia. IL6
84 30458319 10.1016/j.leukres.2018.11.004 2019 Systemic lupus erythematosus and lymphoma: Incidence, pathogenesis and biology. IL6
85 30485406 10.1111/bjh.15689 2019 Antidiuretic hormone- and interleukin-6-producing angioimmunoblastic T-cell lymphoma associated with syndrome of inappropriate antidiuretic hormone secretion. IL6
86 30592279 10.3892/mmr.2018.9783 2019 Protective effect of dihydromyricetin revents fatty liver through nuclear factor‑κB/p53/B‑cell lymphoma 2‑associated X protein signaling pathways in a rat model. IL6
87 30628689 10.3892/mmr.2019.9827 2019 Low‑dose lipopolysaccharide inhibits neuronal apoptosis induced by cerebral ischemia/reperfusion injury via the PI3K/Akt/FoxO1 signaling pathway in rats. IL6
88 30864712 10.3892/mmr.2019.10014 2019 Estrogen receptor β suppresses inflammation and the progression of prostate cancer. IL6
89 31108175 10.1016/j.fsi.2019.05.034 2019 Ctenopharyngodon Idella STAT3 alleviates autophagy by up-regulating BCL-2 expression. IL6
90 31173173 10.3892/ijmm.2019.4230 2019 Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the activation of the JAK2/STAT1 pathway. IL6
91 31180523 10.3892/mmr.2019.10273 2019 Resveratrol alleviates inflammatory injury and enhances the apoptosis of fibroblast‑like synoviocytes via mitochondrial dysfunction and ER stress in rats with adjuvant arthritis. IL6
92 27098052 10.1039/c6lc00229c 2018 In vitro micro-physiological immune-competent model of the human skin. IL6
93 27489357 10.18632/oncotarget.10966 2018 Increased frequency of circulating Th22 cells in patients with B-cell non-Hodgkin's lymphoma. IL6
94 27924864 10.1038/srep38671 2018 Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma. IL6
95 28061377 10.1016/j.bcmd.2016.12.011 2018 TNF-α increases in the CSF of children with acute lymphoblastic leukemia before CNS relapse. IL6
96 28092896 10.1182/blood-2016-02-700575 2018 Primary effusion lymphoma and concurrent progressive Kaposi sarcoma associated with elevated interleukin-6. IL6
97 28341757 10.1158/1055-9965.EPI-16-1012 2018 Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis. IL6
98 28656237 10.3892/mmr.2017.6865 2018 Matrine increases the inhibitory effects of afatinib on H1975 cells via the IL‑6/JAK1/STAT3 signaling pathway. IL6
99 28713932 10.3892/mmr.2017.6927 2018 Human trypsin inhibitor reduces the apoptosis of lipopolysaccharide‑induced human kidney‑2 cells by promoting mitochondrial fusion. IL6
100 28791394 10.3892/mmr.2017.7158 2018 Identification of key genes and pathways associated with classical Hodgkin lymphoma by bioinformatics analysis. IL6